Filters

Drug safety

Showing results (1731-1740 of 3,105) with videos related to

Pageof 311
Sort By:
Drug Safety|September 16, 1999
Felbamate in epilepsy therapy: evaluating the risksJ M Pellock
Drug Safety|May 7, 1999
Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?B Lindelöf
Drug Safety|May 7, 1999
A risk-benefit assessment of HIV protease inhibitorsG J Moyle, B G Gazzard
Drug Safety|May 7, 1999
Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugsP J Sessink, R P Bos
Drug Safety|May 7, 1999
Treating allergic rhinitis in pregnancy. Safety considerationsP Mazzotta, R Loebstein, G Koren
Drug Safety|May 7, 1999
Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrationsJ D Lalau, J M Race
Drug Safety|April 30, 1999
Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting systemO Spigset
Drug Safety|December 1, 1993
Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilitiesA Del Favero, F Roila, M Tonato
Drug Safety|February 1, 1994
Clinical toxicity of the interferonsT Vial, J Descotes
Drug Safety|April 1, 1995
Ocular adverse effects of neuropsychiatric agents. Incidence and managementT Oshika
Pageof 311

Showing results (1731-1740 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|September 16, 1999
Felbamate in epilepsy therapy: evaluating the risksJ M Pellock
Drug Safety|May 7, 1999
Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?B Lindelöf
Drug Safety|May 7, 1999
A risk-benefit assessment of HIV protease inhibitorsG J Moyle, B G Gazzard
Drug Safety|May 7, 1999
Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugsP J Sessink, R P Bos
Drug Safety|May 7, 1999
Treating allergic rhinitis in pregnancy. Safety considerationsP Mazzotta, R Loebstein, G Koren
Drug Safety|May 7, 1999
Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrationsJ D Lalau, J M Race
Drug Safety|April 30, 1999
Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting systemO Spigset
Drug Safety|December 1, 1993
Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilitiesA Del Favero, F Roila, M Tonato
Drug Safety|February 1, 1994
Clinical toxicity of the interferonsT Vial, J Descotes
Drug Safety|April 1, 1995
Ocular adverse effects of neuropsychiatric agents. Incidence and managementT Oshika
Pageof 311
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us